Session VIII: T-Cell Lymphoma 

Session Chairs: Ali Bazarbachi, MD, PhD and Barbara Pro, MD

Revisiting the Immunology of CTCL | Larisa J. Geskin, MD, FAAD | Columbia University, New York, New York, USA

Epigenetic Approaches to Treat TFH Cell Lymphoma | Enrica Marchi, MD, PhD | Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Targeted Therapies for T Cell Lymphomas – a Personalized Treatment Approach | Robert Stuver, MD | Memorial Sloan Kettering Cancer Center, New York, New York, USA

Targeted Therapy of Adult T-Cell Leukemia Lymphoma | Ali Bazarbachi, MD, PhD | American University of Beirut, Beirut, Lebanon

Autologous vs Allogeneic Transplant for T Cell Lymphomas | Norbert Schmitz, MD | University Hospital Muenster, Münster, Germany

Oral Abstract | TBD | Speaker | Affiliation